UK Trade & Investment is the government organisation that helps UK-based companies succeed in the global economy.

We also help overseas companies bring their high quality investment to the UK's dynamic economy – acknowledged as Europe's best place from which to succeed in global business.

UK Trade & Investment offers expertise and contacts through its extensive network of specialists in the UK, and in British embassies and other diplomatic offices around the world. We provide companies with the tools they require to be competitive on the world stage.

For further information please visit www.uktradeinvest.gov.uk or telephone +44 (0) 20 7215 8000

Whereas every effort has been made to ensure that the information given in this document is accurate, neither UK Trade & Investment nor its parent Departments (the Department for Business, Enterprise & Regulatory Reform, and the Foreign & Commonwealth Office) accept liability for any errors, omissions or misleading statements, and no warranty is given or responsibility accepted as to the standing of any individual, firm, company or other organisation mentioned in this document.

Published by UK Trade & Investment March 2010© Crown Copyright

Details correct at time of print. Profiles provided by UK companies and organisations, or from public sources. Profiles may have been shortened

ww

w.u

ktra

dein

vest

.gov

.uk

UK HEALTHCARE EXPERTISE FOR INDIA

The UK is a world leader in research, development, and innovation, and is home to some of the world’s most distinguished scientists and innovators. A country that excels in driving science and innovation right through to market success, the UK is chosen by many global companies as their first choice to do business with and from.

UK TRADE & INVESTMENTYOUR PARTNER TO RAISE HEALTHCARE STANDARDS

UK Trade & Investment (UKTI) can help you rise to the exciting opportunities and challenges that globalisation offers. UKTI in India has a dedicated team across major metros and cities, to help you identify the best UK products, services and partners to help you with your business. UKTI also can help companies work with UK partners to ensure their success in setting up or expanding their business in the UK.

HOW DOES IT WORK?

At UK Trade & Investment, we work with you to understand your business, your strategic objectives, and help reduce cost, time and effort involved in selecting the right trading partner or distributor from the UK. With access to our policy makers, Government Departments, and UK businesses, we offer a unique service to Indian companies by:

�identifying the right UK manufacturers and suppliers

�connecting you with UK companies looking for Indian partners or suppliers

�enabling technology transfers or joint ventures by facilitating interaction with visiting business delegations from the UK

�enabling you to connect with UK Trade Associations such as the Association of British Healthcare Industries (ABHI), to share knowledge, business potential and opportunities for business.

HEALTHCARE IN THE UK

THE UK HEALTHCARE SECTOR HAS NEVER BEEN IN BETTER SHAPE. IT HAS DEVELOPED INTO ONE OF THE WORLD’S MOST DIVERSE AND DYNAMIC MARKETPLACES, BOASTING A HIGH NUMBER OF MAJOR COMPANIES AND A WEALTH OF SMES.

Healthcare in the UK

Contact Details

Leading Science and Product Innovation

Wound Care and Advanced Wound Care Management

In-vitro Diagnostics

Orthopaedics

Dentistry

Operation Theatre Equipment

Patient care and Rehabilitation

e-Health and Telemedicine

Consumer Healthcare

Respiratory Anaesthetics

Medical Education and Training

Private Public Partnerships

Design and Building of Healthcare Facilities

Consultancy

Healthcare Information technology

CONTENTS

2

4

6

10

14

19

24

28

32

34

36

40

42

48

50

56

60

2 3

NEW DELHI

Sunita KapoorSenior Trade & Investment AdviserSunita.Kapoor@fco.gov.uk

British High CommissionCommercial SectionShantipath, ChanakyapuriNew Delhi 110 021 Tel: +91 11 2419 2100 / 2575Fax: +91 11 2687 0062

KOLKATA

Shehla Raza Hasan Trade & Investment AdviserShehla.Hasan@fco.gov.uk

British Deputy High Commission1A, Ho Chi Minh SaraniCalcutta 700 071Tel: +91 33 2288 5172-5 Extn 2236Fax: +91 33 2288 3435

CHENNAI

D RameshTrade & Investment AdviserD.Ramesh@fco.gov.uk

British Deputy High CommissionCommercial Section20 Anderson Road, Chennai 600 006Tel: +91 44 4219 2151 / 70Mobile: +91 95000 90686 / 98407 17882Fax: +91 44 4219 2321

HYDERABAD

Arun PillaiHead of British Trade Office,Arun.Pillai@fconet.fco.gov.uk

British Trade Office Level 1, Midtown PlazaRoad No.1, Banjara HillsHyderabad 500 034Tel: +91 40 6459 9147 / 4433 4134Mobile: +91 98660 16747

MUMBAI

Anjali MalkaniSenior Trade & Investment AdviserAnjali.Malkani@fco.gov.uk

British Deputy High Commission11th Floor, Naman ChambersC/32, G Block, Bandra Kurla ComplexBandra (E), Mumbai 400 051Tel: +91 22 6650 2177 (D) 2222 (Board)Fax: +91 22 6650 2344

BANGALORE

Priya VaradarajanSenior Trade & Investment Adviserpriya.varadarajan@fco.gov.uk

British Deputy High Commission23 Prestige TaktKasturba Road CrossBangalore 560 001Tel: +91 80 2210 0200Fax: +91 80 2210 0400Mobile: +91 98451 33896

We have staff in the top 9 metropolitan areas,and you can directly contact our dedicated team members based in India.

You can also log on towww.uktradeinvest.gov.uk for more details.

CONTACT US

NEW DELHI

MUMBAI

CHENNAI

BANGALORE

KOLKATA

HYDERABADM

ap n

ot to

sca

le a

nd is

for i

ndic

ativ

e pu

rpos

es o

nly

CHANDIGARH

PUNE

AHMEDABAD

4 5

Hospitals from Africa to Australia have benefited from British healthcare expertise, using medical devices, treatments and processes created by innovators in the UK, that have revolutionised the way healthcare is managed and administered the world over. The industry's focus is on innovation and creation of cutting edge, workable and affordable medical devices and technologies.

The medical technology sector in the UK consists of 2,771 companies generating £10.6 billion of annual turnover in a complex market, covering products from consumables such as disposable surgical gloves to systems that enable surgeons to see inside the body as they carry out minimally invasive surgery. The UK is home to 340 companies working in the medical field with a turnover that is greater than £5 million. 43% of the companies in the sector are less than ten years old and 67 new companies have been formed in the last two years. The sector is constantly innovating to meet and exceed patient needs and treatments.

Four segments; wound care management, in-vitro diagnostics, orthopaedic devices and single use technology are the largest segments by turnover, each with just over £1 billion in sales. Together they make up 40% of the total UK turnover in the healthcare sector. The professional services, in-vitro diagnostics, single use diagnostics, wound care and orthopaedic devices segments contain 41% of all employees in the sector. The sector is supported by a strong network of specialist suppliers (segmented as professional services), which is the segment with the largest number of companies and employees.

The National Health Service (NHS) has been key to driving innovation. An annual budget of over £100 billion has helped suppliers focus on developing products which will help the NHS meet its objectives of patient care, at the best possible price. The size of NHS procurement means that companies can be ambitious in their innovation in the knowledge that a significant volume of sales can be achieved. The NHS has innovation teams which scout for the latest technology and products to raise health standards. This focus and support for innovations has benefited the wider healthcare sector in the UK and beyond.

The UK has leading expertise in a number of fields and is open to sharing knowledge and capability with Indian partners. Medical disciplines recognised for their excellence include:

�cardiology�cardio-thoracic surgery �gastroenterology �orthopaedics & joint replacement surgery�neurology �critical care medicine�nephrology �oncology �hand & micro surgery �reproductive medicine

LEADING SCIENCE AND PRODUCT INNOVATION

6 7

UK companies produce the full range of high quality, needed in a modern healthcare facility, from essential laboratory equipment and beds, to super speciality operation theatres and associated equipment needed for procedures and diagnostic work. Recent innovations in Telemedicine are being used to help leverage telecommunication technology, to deliver healthcare and education to patients in regions that are geographically less accessible.

The has been key to the healthcare sector’s success. Academics work closely with hospitals and companies to translate academic solutions into practical products and services. The size of the NHS enables academics and companies to quickly test and assess the clinical applicability of new products and services, due to the NHS having pools of patients ready to participate in research programmes.

In addition to , the UK has over the years developed a

sector of specialists who work with healthcare providers to tackle problems and raise standards. These consultants advise on all areas of healthcare, from the setting up of processes for primary care, through to advising on management of hospital facilities, to enable the efficient allocation of resources. Many of the consultants have global networks to assist healthcare providers around the world.

Central to recent improvements in UK healthcare provision has been huge investments made with the private sector on (PFIs). The use of PFI schemes puts healthcare

high durability equipments

UK’s strong science base

universities supporting product research

Private Finance Initiatives

providers and private sector funders together, so that the private sector takes some of the risk of large projects and at the same time commits to running or delivering specific health services for a specific time period (generally about 20 years). The consultants who design the PFI schemes also work with building and facilities management contractors to add value to projects by acting as project managers and as such can help manage the design, build, equipping and running of hospitals. Using the PFI model, Central Manchester hospital was redeveloped at a cost of about £400 million. The now unified hospital complex combines traditional hospital wards, research units as well as academic and industry partners, to encourage better and faster development and delivery of health solutions. PFI has been a recent addition to UK healthcare but it has grown rapidly.

The healthcare sector is continually changing and offers some exciting products, services and concepts that should improve health for all. Whether it is medical devices, new equipment or digitalisation of health, the UK holds a leading position. are offering solutions that were science fiction until recently. Recent work on internal diagnostic products, such as camera pills which can broadcast real-time pictures from swallowed pills passing through the body, are just one of many advances that could improve the lives of millions. Regenerative medicine, an area the UK is leading in, could be the greatest advance since the discovery of penicillin. These are exciting times and the UK healthcare sector is ready to share ideas and work with India.

Advances in technology

Step 1 - Please identify the areas you are interested in.

Step 2 - Contact one of our team of specialists in India who can help introduce you to the UK companies or find others not in this booklet who are also keen to support healthcare in India.

Step 3 - Talk direct to the companies you are introduced to, but if you don't find what you need, please ask one of our team to see if they can find other options for you.

In a global market place global solutions to health problems are required, and UK Trade and Investment in India is ready to help you find the best the UK has to offer for you.

The UK has a long history of working to help meet patient needs in India. Recent years have seen an increase in the number of UK providers who can support healthcare projects in India, either through having operations in India, or by having established partnerships with Indian firms to deliver cost effective solutions.

UK COMPANIES IN INDIA IDENTIFYING YOUR UK PARTNER

8 9

Advanced wound care is based on the principle of moist wound healing, whereby wounds have been shown to heal faster without pain and with minimal scarring if a moist healing environment is maintained. Products include gels, films and foams and anti-microbial dressings to treat and prevent wound infection.

This new system of care brings multiple benefits to patients and clinicians alike from less discomfort and pain, a reduced need to constantly apply fresh dressings, faster healing times and reduced risk of complications which can lead to infection and, in some cases, amputation.Valued at over £ 1.1 billion in 2009, the advanced wound management sector in the UK employs around 4000 people. It comprises active or moist conducive products as well as interactive products like artificial skin, graft materials, growth factor and biomaterial dressings.

UK Universities are also leading the way with respect to research in wound care, with Cardiff University in particular, making great strides in this sector through its world leading Wound Care Healing Research Unit. This unit is one of the

largest multi-disciplinary units in the world and has a key objective to ensure that any new product development is in line with patient and clinical needs. The unit also works closely with manufacturers of high technology and basic wound care products and NHS Trusts.

The UK is strong in the wound care sector, driven by early adoption of moist dressings and boosted by the presence of some of the world's leading wound care players, including Smith & Nephew, Smiths Medical, Ethicon amongst others.

Many industry developments to design, assess and use new products and treatment regimes, have resulted from collaboration between UK-based companies, hospitals, universities, and research units. Examples include:

SMITH & NEPHEW is a focused high technology medical device business with leading market position in Advanced Wound Management (comprising advanced wound care products for Leg Ulcers, Malignant Wounds, Pressure Ulcers, Burn Care, Foot Ulcers, Scar Management, IV Therapy and Post-Surgical Wounds). Hull, UK, is the primary manufacturing site and headquarters of global marketing, product development and business management. In India since the late 1950s, Smith & Nephew made a giant foray in the advanced wound care segment in 2006, emerging as market leaders.

Smith & Nephew products include advanced polymeric gels, films and foams that create a moist environment that encourages wound healing; and antimicrobial dressings for treating and preventing wound infection. Potential benefits to patients include fewer reapplications of dressings, less discomfort and pain, faster healing and reduced risk of complications such as infection and amputation. Treatment is clinically effective and less time-consuming and therefore more cost effective. Products currently marketed in India include Surgical Incise Drapes & Film Dressings (OPSITE™), Post-Operative Dressings (MELOLIN™, PRIMAPORE™, OPSITE POST-OP™), Nanocrystalline Silver Dressing for Infection Management (ACTICOAT™), Hydrogel for Chronic Wounds (INTRASITE™), Silicon Gel Sheet for Scar Management (CICA-CARE™), Hydrocellular Foam Dressing for Chronic Wounds (ALLEVYN™) and Paraffin Gauze Dressings (JELONET™, BACTIGRAS™).

The company's advanced medical devices for wound management include Hydrosurgical Debridement (VERSAJET™) and Negative Pressure Wound Therapy (RENASYS™). These products will soon be launched in India. Smith & Nephew is well known for its high quality products, as well as training and education of healthcare professionals. Currently, Smith & Nephew wound management products are used in leading hospitals in India. Key customers include the Indian Armed Forces, Central & State Government Hospitals, and leading corporate hospital chains such as Apollo, Max & Fortis. Smith & Nephew are headquartered in Mumbai. For more details please visit www.global.smith-nephew.com

WOUND CARE ANDADVANCED WOUND CARE MANAGEMENTADVANCED WOUNDCARE MANAGEMENT IS A FAST GROWING HEALTHCARE SECTOR

THE UK IS A GLOBAL PLAYER IN THE WOUND CARE MARKET WITH SOME OF THE WORLD’S LEADING WOUND CARE COMPANIES BEING BASED, OR HAVING MANUFACTURING FACILITIES IN THE UK.

10 11

PHYSICOOL LTD. has recently introduced Physicool, a new and unique, stretchy, reusable bandage that combines cooling, compression and support. Physicool provides instant treatment for inflammation and bruising of muscles, tendons and ligaments. It is highly effective and quickly reduces swelling and pain. The bandage can be applied in seconds, and its effects are long lasting, even after the bandage is removed.

Manufactured in East Yorkshire and designed by Kay Russell, it quickly and efficiently treats inflamed muscles, tendons and ligaments, and rapidly reduces excess swelling and discomfort after injuries. The revolutionary new bandage is useful in managing strains, sprains and bruising, for new trauma or existing conditions. It is an ideal sports, first-aid or medical product.

Physicool Ltd. has tied up with Sant Meditek of Bangalore, to offer the product in India, for sports and healthcare applications. International cricket coach Dav Whatmore, who trains elite players in India, has been very pleased with the results of using Physicool, as it provides pain relief without pills and cooling and without the need for refrigeration. Physicool is also ideal for post operative care after orthopaedic surgery and in accident and emergency wards for instant First Aid.

For more information visit www.physicool.co.uk or www.santmeditek.com

TG EAKIN LTD. is a medical device manufacturer that specializes in the fields of ostomy and woundcare. Based in Northern Ireland, the company distributes their goods to 30 countries throughout the world. Within the past 2 years they have began exporting to India and goods are sold through 2 distributors, Sheth Impex Vivo Solutions P Ltd., (South East India) and Nilesh Surgicals (West India). All products manufactured by TG Eakin Ltd. are made to the same high standard and go through stringent quality control procedures before leaving the factory.

The products currently manufactured by the company include:

Cohesive Seals – An ostomy skin barrier used to protect the skin against corrosive output from stomas and wounds, creating comfort and security for the user. Demand for the company's inaugural product, Cohesive Seal, grows annually, with 14.7 million being sold in 2009 alone. In a recent survey of 2700 patients it was found that 99.6% of users agreed that Cohesive is an essential part of their stoma care routine.

Cohesive Paste – An alcohol-free stoma paste that acts in the same way as Eakin Cohesive Seals and provides the same level of protection for peristomal skin by absorbing moisture, reducing digestive enzyme activity, maintaining a natural pH and blocking biological and chemical irritants from coming into contact with the skin.

Wound Pouches – Wound drainage bags for use with wounds and fistula, derived from trauma, surgery or cancer. Available in a range of sizes, they provide a comfortable, skin friendly, cost effective and time saving solution.

Pelican Pouches – A comprehensive range of Ostomy pouches used to collect stoma output, available in soft convex, flat and paediatric ranges.

With an advanced Research & Development department, this innovative company is set to introduce more new products to the range in the near future.

For more details log on to www.eakin.co.uk

THE UK REGULATORY ENVIRONMENT IS OPEN TO INNOVATIVE TECHNOLOGIES IN ADVANCED WOUND MANAGEMENT AND THE NHS IS HIGHLY RECEPTIVE TO NEW TREATMENTS AND PRODUCTS.

12 13

The UK in-vitro diagnostics market turnover is currently valued at over £1 billion, comprising test kits, reagents and associated analytical instrumentation - anything from simple over-the-counter pregnancy kits to sophisticated products needed for the diagnosis of cancer.

Traditionally, IVD techniques have been used in diagnosis and monitoring of acute illness. Technological advances have meant that the sector has evolved, with IVD products being used in the early detection of conditions requiring therapy and in the prediction and prevention of disease.

The UK’s strong research base has been central to the development of hi-tech IVD products. Breakthroughs in molecular biology have led to new tests for diagnostic enzymes, proteins and antibodies and, as research continues, an increased understanding of the relationship between genetics and disease will lead to the development of new tests.

The UK has also been instrumental in developing IVD devices for testing cardiovascular risks, cancer, diabetes, infectious diseases and osteoporosis. These products have the potential to revolutionise the way in which healthcare is delivered, and to cement the UK as a leader in IVD.

All sizes of company –from multinationals to start-ups – operate in the UK IVD industry. These companies are located across the UK, with clusters around Oxford, Cambridge and in Scotland. UK-based IVD companies include the following:

RANDOX LABORATORIES LTD. started in 1982 with an aim to revolutionise healthcare through continuously improving diagnostic solutions globally. Randox continues to improve diagnostic solutions, offering rapid and accurate patient diagnosis. Due to its innovative and revolutionary nature, Randox rapidly expanded across the globe. Randox now operates from 25 international offices worldwide, including India.

India led the way for Randox’s expansion with a distribution agreement established in 1986. A Randox office was opened in India in 2002, with Randox India Pvt. Ltd. launched in January 2009, and headquartered in Mumbai. India is now one of their largest and fastest growing markets. All the Randox staff in India, undergo training at Randox HQ in the UK, and a strong bond is maintained between the HQ and the Indian office via excellent communication channels and International Sales Conferences.

Randox are dedicated to the research, development and manufacture of innovative solutions for the in-vitro diagnostic market. With heavy re-investment into R&D annually, Randox products use the latest technology and are of the highest quality. Their product range is extensive, meeting the needs of many types of laboratories including clinical, research, forensic and veterinary. They provide a comprehensive range of reagents and clinical chemistry analysers, the RX Series. Their Quality Management Solutions is the best available, with quality control material, an IQC program and the largest global EQA scheme in the world, RIQAS, which offers 15 programmes.

Randox Life Sciences meets all the antibody and protein needs complete with an online ordering service. Randox are the creators of Biochip Array Technology, a unique multiplexing technology to facilitate faster, more accurate patient diagnosis. Available Biochip Arrays include Adhesion Molecules, Antimicrobials, Cardiac, Cytokine, Cerebral, Drugs of Abuse, Endocrine, Fertility, Thyroid, Synthetic Steroids, Tumour Markers and Colorectal Cancer DNA Array.

For more information visit www.randox.com

IN-VITRO DIAGNOSTICSINNOVATIONS IN IVD ARE TRANSFORMING THE WAY HEALTHCARE IS DELIVERED

THE UK HAS AN EXCELENT TRACK RECORD OF DEVELOPING AND EXPORTING WORLD-CLASS IN-VITRO DIAGNOSTIC (IVD) PRODUCTS

14 15

Located in Scotland, United Kingdom, OMEGA DIAGNOSTICS GROUP PLC is an AIM-listed public company on the London Stock Exchange. The Group provides high quality IVD products for use in Hospitals, Blood Banks, Clinics and Laboratories in over 100 countries. There are three companies in the Group: Omega Diagnostics Ltd. specialises in the diagnosis of infectious diseases; Genesis Diagnostics Ltd., manufacture a range of ELISA kits for Autoimmune Diseases and Food Intolerance; Cambridge Nutritional Sciences Ltd. launched the world’s first self test for Food Intolerance; the Food Detective™ detecting IgG antibodies for up to 59 common foods. They also provide a more in depth food profile though their laboratory service. In September 2009, the Group acquired Co-Tek, a manufacturer of bacterial diagnostic reagents.

Omega Diagnostics Group PLC has been successfully providing high quality products in India since 1993 alongside the Qualigens Division of Glaxosmith Klein (GSK). However, since 2007, when Thermo Fisher in Mumbai, India, acquired the Qualigens Division from GSK, Omega have formed a strategic alliance with Thermo Fisher as exclusive distributor. Omega’s Pathozyme TB ELISAs are currently the leading brand of TB tests in India.

For more information please visit: www.omegadiagnostics.com – Omega Diagnostics Ltd.www.elisa.co.uk – Genesis Diagnostics Ltd. www.camnutri.com – Cambridge Nutritional Sciences Ltd.

Established in 1983, AXIS-SHIELD is a pioneering organisation focused on the development and manufacturing of important in-vitro diagnostic tests for use in clinical laboratories and at the point of care. In the laboratory sector they specialise in proprietary markers for diagnosis and management of critical illnesses such as cardiovascular and neurodegenerative diseases and rheumatoid arthritis. One of their key products is a new Liquid Stable 2 reagent enzymatic homocysteine assay, with applications for use on popular clinical chemistry platforms. They also have EIAs for homocysteine, anti-cyclic citrullinated peptide (CCP), and Active B12 (holotranscobalamin).

The group comprises a Laboratory Division in Dundee, a Point-of-Care Division in Oslo, and direct sales and distribution subsidiaries in the USA (Axis-Shield US), UK (Axis-Shield UK), Switzerland (Axis-Shield AG), Germany (Axis-Shield GmbH) and Norway, Sweden, Denmark, Finland (all Medinor).

For more details visit www.axis-shielduk.com

THE UK HAS AN EXCELENT TRACK RECORD OF DEVELOPING AND EXPORTING WORLD-CLASS IN-VITRO DIAGNOSTIC (IVD) PRODUCTS

USEFUL CONTACTTHE BRITISH IN-VITRO DIAGNOSTICS ASSOCIATION (BIVDA)www.bivda.co.uk

16 17

Orthopaedics is an area of strength for the UK, with significant research as well as manufacturing taking place. The sector comprises joint implants, spinal implants, bone grafting, trauma devices and other forms of support. New precision machining processes are currently under development and the UK’s skills and experience in this area have been making it a global leader in the field.

Leading UK-based players, include DePuy Orthopaedics, Biomet, and Smith & Nephew. Alongside a strong manufacturing base, the UK has an enviable position with regards to orthopaedics research, particularly the work being undertaken into novel materials and tissue engineering.

Yorkshire has the largest cluster of orthopaedic companies in the UK with global manufacturing sites of Johnson & Johnson, DePuy, Symmetry Medical, Doncaster Medical Technology, B Braun, JRI and strong centres of academic and clinical excellence around the area. University College London is undertaking research into the development of tissue-engineered implants to treat bone defects in revision total hip replacements and the development of doped phosphate glasses to prevent orthopaedic infections.

The University of Leeds is also working alongside the international orthopaedic industry with the support of the Engineering and Physical Sciences Research Council. The main focus of these working relationships is to develop minimally invasive approaches for joint repair and replacement, and engineering approaches for soft tissue regeneration.

DePuy, with its orthopaedics R&D headquarters based in Leeds, has been the location of ground-breaking work using facilities at the Leeds University. A multidisciplinary group of clinicians, biologists and engineers is researching and developing new prosthesis and therapies for tissue replacement and regeneration.

Smith and Nephew’s York research centre is leading the way on the production of new materials – from improved knee replacements to extending the life of hip replacements by reducing wear and tear. UK Universities are also investigating how existing technologies can be improved, for example, scientists at the University of Southampton are using computational methods to predict the robustness of cementless total hip replacements, while the University of Leeds is undertaking research into wear prediction of artificial limb joints.

ORTHOPAEDICSSIGNIFICANT INNOVATIONSIN ORTHOPAEDICS HAVE MADE IT A LEADING SECTOR IN UK HEALTHCARE

18 19

SMITH & NEPHEW develops and markets advanced medical devices that help healthcare professionals treat patients more effectively - and help them get back to their lives faster. Their dedicated Global Business Units are - Orthopaedic Reconstruction, Orthopaedic Trauma, Clinical Therapies and Advanced Wound Divisions.

They offer the widest range of orthopaedic reconstruction joint bearing services available with their joint replacement systems for knees and hips that help patients regain their normal life.

Smith & Nephew made direct inroads in India in the orthopedic business in February 2008, through their company Smith & Nephew Healthcare Pvt. Ltd. In joint reconstruction, hip and knee implants, the company’s growth has been driven by the introduction of a unique new material in orthopaedics: OXINIUM™ Oxidized Zirconium. The company sells hips, knees and uni-compartmental knees and also Patello-femoral Joints made of this strong, hardwearing material.

The introduction of technologies and materials like OXINIUM™ for hip and knee implants and products such as the BIRMINGHAM HIP™ Resurfacing (BHR™) and the JOURNEY DEUCE™ knee are expanding the patient base and therefore the market, providing opportunities to treat younger patients.

Smith & Nephew continually develop new materials and techniques to meet the growing demands of patients and hospitals for tougher, longer-lasting implants. This makes them suitable

for younger patients as well. Smith & Nephew also work with surgeons to improve techniques and instruments to reduce the invasiveness and surgical time required for joint replacements, resulting in faster healing and associated health care efficiencies. Some of their key products include: BIRMINGHAM HIP™ Resurfacing System, R3 Acetabular Cup System, EMPERION™ Modular Hip System. LEGION™ Revision Knee System, JOURNEY™ Bi-cruciate Knee system, OXINIUM™ Oxidized Zirconium, a unique bearing surface for longer lasting joint replacement, SYNERGY™ Primary Hip Systems, ECHELON™ Revision Hip System and GENESIS™ Primary Knee Systems.

Smith & Nephew is recognized for its innovative and broad range of products, in particular their easy to use instruments by orthopedic surgeons. Some of their major customers include the giants like Apollo Hospitals, Indian Armed Forces, Central & Government hospitals, and the Fortis Group of hospitals.

Smith & Nephew Endoscopy is the global market leader in minimally invasive surgery for joints. They offer a complete range of arthroscopic products for Knee and Shoulder. Some of the leading brands currently marketed in India include ENDOBUTTON™ CL ULTRA which is the Gold Standard in ACL/PCL Fixation, ULTRA FAST-FIX™ which has proven clinical success in Meniscal Repair, BIOABSORBABLE SCREWS, ACUFEX™ Hand Held Instruments, ELITE™ BLADE FAMILY, BIORAPTOR™ Suture Anchor – For easy and exact positioning, TWINFIX™ Suture Anchors with ULTRABRAID™ Suture - For Strong & Secure Shoulder Repair, ACCU-PASS™ Suture Shuttle – For precise control of Suture Placement and

GROUND BREAKING ADVANCEMENTS HAVE BEEN MADE IN THE UK ORTHOPAEDICS SECTOR LEADING TO MAJOR IMPROVEMENTS IN PATIENTS’ QUALITY OF LIFE

Shuttle Deployment. Smith & Nephew also has a complete range of capital arthroscopic products like DYONICS™ Power Shaver System, 560P HD camera System, DYONICS™ 25 Pump, DYONICS™ Light Source (300XL), DYONICS™ Vulcan Arthroscopy System with monopolar and bipolar probes and 660 Image Management System.

Smith & Nephew Endoscopy products are used in leading hospitals in India. For more details visit www.global.smith-nephew.com

20 21

Since launching in India, Touch Bionics has fitted several upper limb amputees with the i-LIMB Hand at various locations around the subcontinent, and is working to further establish the company's presence in the region by establishing relationships with Indian prosthetists and clinics. The launch of ProDigits now opens up the possibilities of advanced bionic technology to many more patients, and the company is looking forward to helping Indians with partial hand injuries that have previously had no powered prosthetic solution available to them.

For more information, visit www.touchbionics.com

ENDOLITE INDIA LTD. is a joint venture of International Society for Human Welfare and Rehabilitation (ISHWAR) and CHAS A. BLATCHFORD & SONS LTD., UK, the number one name in artificial limbs, the world over. Endolite ushered in a dramatic technological change in Prosthetics by introducing carbon fiber composite materials, which ensure superior strength, and are extremely lightweight and easy to mould. Endolite Prosthetic & Orthotic Centres across India provide world-class facilities with Prosthetic and Orthotic fitments being handled by highly qualified and skilled Prosthetists and Orthotists.

Endolite systems cover all levels of amputation of the lower limbs with special attention paid to the design of joints like ankle, knee and hip. The Endolite range includes state of the art Smart IP (Intelligent Prosthesis): computerized above the knee, the only one of its kind available anywhere in the world. The range covers various swing phase control mechanisms, the stance flex stabilized knee, the four bar knee and hip joints, the four bar child system, the silicone socket. The latest in the range is the Adaptive Knee, which has a programmable swing and stance control allowing control on all types of terrain including stairs and slopes. A new range of prosthetic feet have been added to its inventory. These include the Echelon, Elite VT, Elite, Espirit, DR-II, Navigator and the Multiflex Foot. In addition, there is the very low cost ATLAS system. A simple yet, sophisticated design, ATLAS combines superb functionality and durability.

The company also has a wide range of Cosmetic, Mechanical and Select Myo-Electrical Hands. These are available for children, juveniles and adults. Its Myo Electric hand combines optimum control function with a good cosmetic restoration, and is available in different sizes to cover the needs of most amputees. It also has various Elbows, which are suitable for all ages. Endolite has a complete range of Silicone cosmetic limbs that satisfy the requirements of most amputees. It undertakes Cosmetic Restorations for fingers, toes, hands, feet, ears, eyes etc. Custom fabricated and carefully sculpted, these are lifelike and real in shape, size, colour and appearance. The restorations are custom fabricated to achieve proper proportions and correct skin pigmentation and perfect colour match. The company also introduced Gel Care products. The range includes Diabetic/arthritic gel socks. It is an innovative way to provide gel protection to the sole of the foot. In addition there are digital pads and caps, heel pads and cups, toe spreaders and various their protective foot care products.

For more information visit www.endoliteindia.com

Pict

ure

cour

tesy

Tou

ch B

ioni

cs

22 23

TOUCH BIONICS is a leading developer of advanced upper-limb prosthetic devices. The company has brought to market both the i-LIMB Hand, a first-to-market prosthetic device with five individually powered digits and, most recently, ProDigits, the world's first bionic solution for amputees with missing fingers. Additionally, Touch Bionics' acquisition of U.S. company, LIVINGSKIN, has enabled it to apply its commercial and technical expertise into advanced coverings for multi-articulating hands and digits. The company continues to develop leading-edge technologies for the treatment of patients with upper-limb deficiencies.

In 2009, Innovative Prosthetics & Orthotics Pvt Ltd., officially launched the i-LIMB Hand in India, and is official distributor for Touch Bionics in the country. New Delhi-based Innovative Prosthetics & Orthotics is a leader in the prosthetics and orthotic industry in India and has pioneered several innovative services to clinics and hospitals. The bionic hand is arguably the most revolutionary of the prosthetic products it has brought to India. Touch Bionics' market entry into India was strongly supported by the excellent work of Scottish Development International's New Delhi operations.

The UK has been at the forefront of leading edge dentistry for over a century. Today the highly regulated sector is focused on innovative products and materials that deliver better results for patients for longer. Today the Dental Appliances Manufacturer Audit Scheme (DAMAS) plays an important role in supporting the manufacture of dentistry related devices. The DAMAS scheme improves efficiency, reduces waste, cuts remake levels and saves times, this in turn enables cost savings to be passed onto customers.

UK research in dentistry has a particular focus on the development and the use of innovative materials. Research at the University of Birmingham is concentrating on the development of new filling material with improved depth cure, through monitoring and analysis of refractive index change through light activated fillings.

Scientists at the University of Leeds are investigating novel aesthetic dental restorative materials, with work into mica-based dental glass ceramics, which are particularly suitable for chair-side processing. Dentistry schools at the University of Leeds and the University of Sheffield are active in the next generation of glass ceramics with high strength and fracture toughness that can bond to enamel, dentine and bone. Technology developments impacting upon the dental market include new bioceramics, improved alloys, fillers and cements, composites, regenerative materials, bone substitutes and drug eluting meshes.

The University of Bristol is looking at the development of automated rapid fabrication of net shape ceramics, work, which could potentially revolutionise current manufacturing technologies in ceramics.

DENTISTRYTHE UK'S DENTAL INDUSTRY SIZE HAS A HIGHLY TRAINED, HIGHLY SKILLED WORKFORCE. UK DENTAL LABORATORIES ARE WELL REGARDED, PARTICULARLY BY THE PRIVATE SECTOR, WITH BEST PERFORMING LABS WORKING ON IMPLANTS.

24 25

Scottish company DENFOTEX has been very successful in both the UK and Germany with its chair-side Photo Activated Disinfection (PAD™) - a minimally invasive treatment that takes just 1 to 2 minutes and eliminates bacteria in all types of oral infection viz. in periodontics, perimplantitis, endodontics and caries. Also, Denfotex is now developing PAD for other medical applications including treatment of fungal foot/nail infections.

For more details on Case Studies and for those interested in purchasing or distributing the PAD please visit www.denfotex.com

Renowned in the dental and jewellery sectors, the hallmark of ATTENBOROUGH rotary brushes over the last 98 years has always been that of quality, all products being manufactured under an ISO 13485 and ISO 9001 quality system audited by the BSI. (British Standards Institution).

Attenborough rotary brushes are made from the finest Chunking bristle and every brush is closely inspected prior to packing to ensure tufts are filled and trimmed properly and retained firmly. All packaging is batch/date numbered for ongoing identification, bearing instructions in English, German, Spanish and French for their international client base.

In addition to their extensive range of rotary polishing products, they also produce a number of other products such as pre-formed wax patterns for dental work, crib wires, mops, miniature handpiece brushes, cones, clasps, backings, wire, perforated plate, gauze, and a full range of laboratory supplies.

They have recently made a considerable investment in the CNC automation of their entire production process, and have also increased their workforce, thus doubling their production capacity to meet a marked increase in demand for their products. This enables them to maintain their extremely competitive prices whilst delivering their lines from stock.

Attenborough's products can be seen at www.attenborough.com

Following eight years of R&D, SmartSeal was launched commercially in 2007 by DRFP LTD, UK, as a radically different, biocompatible root filling material that helps to improve endodontic results. Its two-part active system comprising SmartPoint and SmartPaste is designed to be easy and quick to use, requiring no change of technique, no additional equipment and providing excellent long term results.

The innovative difference with SmartSeal, is that it's the only obturation system available that utilizes hydrophilic polymer technology. When water is absorbed from the tooth tissue, the SmartPoint obturation point swells in the lateral plane only to create an excellent seal and prevent re-infection of the root canal. The SmartPaste root canal sealer also uses hydrophilic polymers to swell into the lateral canals and irregularities in the root to create a tight mechanic seal.

SmartPoints are available in both constant taper and variable taper sizes to fit most file systems, and the SmartSeal range also includes SmartPaste Bio (bioceramic sealer), SmartGauge (to trim constant taper SmartPoints to the correct apical tip size) and SmartTrim (perfect for trimming the excess at the base of SmartPoint once in the canal).

GP-based products have served their purpose for over a century but their limitations are well documented. SmartSeal's unique properties overcome existing inadequacies to improve outcomes for practitioners and patients alike. Since its launch, the system has grown in popularity with converted practitioners commenting about its simplicity of use, its valuable lateral expansion properties that negate the need for accessory points, and the good match of the taper points. Smart Seal's product range can be viewed at the following address www.smart-seal.co.uk

UK DENTAL LABORATORIES HAVE RELATIVELY LOW STAFF NUMBERS, DUE TO THE SMART APPLICATION OF TECHNOLOGY AND PROCESSES. INNOVATION HAS BEEN KEY TO THEIR SUCCESS.

Pict

ure

cour

tesy

DRF

P Lt

d

26 27

Technology in the operating theatre room is critical to reducing the cost and time of patient operations and patient recovery. UK companies have prioritised the development of equipment that is compact and easy to use and maintain.

Recent upgrades of UK hospitals have been able to take advantage of the latest UK technology and products. Advances in operating tables enable the most demanding surgical techniques and faster movement of high risk patients. Surgeons are benefiting from scientifically improved lighting that improves visibility during delicate operations. Innovations in imaging are enabling leading surgeons to connect with other surgeons located hundred of miles away during operations that require the input of multiple experts.

One of the most advanced operating theatres in Europe was unveiled at the Royal Infirmary of Edinburgh (RIE) in Nov 2009. The state-of-the-art facility with its cool blue lighting, high-definition flat-screen TVs, built-in monitors and iPod dock is expected to revolutionise patient care and operating procedures and across the UK.

OPERATION THEATRE EQUIPMENTBRANDON MEDICAL is an award winning British medical technology company with over 40 years of healthcare experience. Their products are in use throughout the world, supported by an extensive distributor network. Brandon Medical are acknowledged experts in Medical Lighting, Medical Power & Control Systems, Medical Architectural Products and Medical Audio Visual Systems, with unique expertise in providing integrated solutions.

As a company they have built up dominance within the UK medical lighting market by continually investing in long-term R&D and Product Innovation projects. Over the last 2 years a total of 13 awards have been presented for Brandon's innovative products.

In India, Brandon have recently tied up with Trivitron, a Chennai based company who has established a high-end medical technology park in Chennai, to distribute their range of products to Indian hospitals. Brandon Medical will manufacture shadow-less lights used for operation theatres by setting up a joint manufacturing facility at Trivitron's Medical Technology Park in Chennai, India, which is currently under construction. The site will provide 50 new jobs to the surrounding town and will be a centre of excellence for innovation and technology.

For more information please visit www.brandon-medical.com

28 29

ESCHMANN EQUIPMENT, a member of the Sisk group of companies, is the leading manufacturer of Operating Theatre Equipment and Sterilizers in UK. Eschmann has over 100 years of history in manufacturing premium medical and surgical equipment and single use products. Eschmann's reputation was boosted in India in 1997, when Indian demand for higher healthcare standards increased. In 1980, India exceeded the standard of many European countries, by building the first state of the art Hospitals with high-tech operating theatres, and fixed installations designed and built by Eschmann for SKIMS, Srinagar (J&K).

Eschmann's reputation has spread throughout India and with the help and support of the current distributor Medex, Eschmann designed and installed 47 operating theatre suites in many reputable and prestigious hospitals in North, South and North-West India within a short period. Eschmann has always proven to be ahead of the curve in terms of medical equipment technology, and, as the leading British manufacturer, it has kept up with India's expectations.

The current Eschmann range of state of the art operating tables, T20, and T30 were introduced to the Indian market by Medex last year. Their sales and service personnel attended extensive training seminars and courses in the UK and Delhi . The new products have been well received in the market as a premium product and Medex have been selling them successfully since their launch.

The Indian market receives special attention and support from Eschmann UK, and Eschmann's sister company in Singapore due to its importance and geographic location. The headquarters of Eschmann's distributor “Medex” is in New Delhi with branches in Bangalore, Chandigarh, Hamirpur (HP) and Kolkata.

Some of the major hospitals in India with operating theatres equipped with Eschmann products are: All India Institute of Medical Sciences, New Delhi, Bokaro Steel Plant, Bokaro, Jharkhand, Escorts Heart Institute & Research Centre, New Delhi, National Institute of Mental Health & Neuro Sciences, Bangalore, Karnataka, Post Graduate Institute of Medical Education & Research, Chandigarh, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, J&K, and The Calcutta Medical Research Institute, Kolkata, West Bengal.

For more details visit www.eschmann.co.uk

Picture courtesy Eschmann Equipment

30 31

CHARNWOOD HEALTHCARE is a UK-based specialist in the manufacture of medical devices to assist with the prevention of pressure sores or decubitus ulcers, including high technology mattresses and supports for operating theatres, recovery rooms, accident departments and other high dependency areas. The majority of hospitals in the UK are now equipped with Charnwood's Liquid Displacement Cell Mattresses.

One area of specialisation is the manufacture of medical devices to assist with the prevention of pressure sores or decubitus ulcers. This includes high technology mattresses and supports for operation theatres, recovery rooms, accident departments and other high dependency areas. Pressure relieving cushions, mainly for wheelchair use and mattresses for both hospital wards and home use are manufactured as part of this range.

For more details visit www.charnwoodhealthcare.com

One of UK's largest producers of equipment used in pressure care, patient positioning and transport is HUNTLEIGH HEALTHCARE. The company manufactures hospital beds and therapy couches, as well as compression devices to aid in the prevention and treatment of deep vein thrombosis.

Arjohuntleigh Healthcare globally offers an extensive range of healthcare solutions for all settings. Huntleigh Technology was acquired by Arjo (part of Getinge group) in early 2007, to form Arjo Huntleigh International globally, and the subsidiary in India is now known as ArjoHuntleigh Healthcare India Pvt. Ltd. The Extended Care division, which includes ArjoHuntleigh, is one of the three independent business areas of Getinge AB. ArjoHuntleigh products are distributed in 150 markets and have very strong market positions.

ArjoHuntleigh in India is a market leader in the Premium Electric bed segment, Pressure Area care systems and Intermittent Pneumatic compression systems. It is generally No.1 or No.2 in most of the segments it operates in. Their Indian subsidiary has presence in 14 cities in India and is also responsible for neighbouring countries like Sri Lanka, the Maldives, Nepal, Bhutan and Bangladesh. The Indian subsidiary is in its 10th year of operation, catering to a wide target audience of Intensivists in ICU, caregivers in Hospitals, doctors , which it hopes to keep on doing for many years to come. ArjoHuntleigh

PATIENT CARE AND REHABILITATIONUK companies are major investors in patient rehabilitation technologies, but academia and NHS partners continue to have a leading role in discovering new health solutions. The Newcastle-based Institute of Ageing, for example, has a large, trained panel of elderly people who are a key resource to identify and test a wide range of assistive technologies to aid independent living. Oxford's Nuffield Orthopaedic Centre is developing, manufacturing and testing new devices to treat back pain. The devices generate feedback from the skin overlying the lower back using vibrators, with the aim of reducing chronic pain. Worcestershire's Motion Analysis Research and Rehabilitation Centre specialises in examining the process of motion, with the technology the being used for rehabilitation. The centre also has a fully equipped physiotherapy and podiatry facility.

product offerings include medical beds, patient lifters, therapeutic services, DVT prevention, wound healing, diagnostics, hygiene and burns therapy equipment, and Akron couches and physiotherapy treatment.

For more information visit www.arjohuntleigh.com

32 33

E-Health covers services that increase the value that physical practice sites can potentially provide patients, as well as providing health information via the internet. The UK is working towards a fully integrated e-Health service and one that complements pan European initiatives too. The aim is to establish a standard health information network infrastructure to facilitate the flow of health information throughout the EU, including the distribution of electronic health cards to all EU citizens and the launch of online health services, including information on healthy living and illness prevention, electronic health records, tele-consultation and e-reimbursement.

There are approximately 120 companies in the UK healthcare IT sector, including several multi-nationals. UK based multi-nationals include BT, which has developed a secure managed network for the NHS called NHSnet and Research in Motion (RIM), which has developed hand held devices to give transplant teams access to patient information.

City University London and Coventry University are working together on 'NHS my-care', research into a new system enabling patients to hold and update their own medical records, it will be particularly useful for those suffering with long-term chronic conditions and improve access to records in the case of acute illness or accident. The research will involve liaison with the international telemedicine community, Connecting for Health, and community groups such as Age Concern.

The Scottish Centre for Telehealth provides a centre of expertise to define and disseminate best practice and develop inter-operable standards, protocols and processes to support telehealth solutions, as well as supporting a range of projects throughout Scotland, focusing on unscheduled care, management of long term conditions, paediatrics, remote and rural support and education.

The UK is also to be home to a national digitalx-ray archiving and communications system, the first in the world and a national programme for safer patient identification, developing and implementing automatic identification technologies.

DANMEDICAL LTD. is an R&D based manufacturer of self contained computer based medical devices, producing and supplying unique state of the art remote electronic, paperless medical diagnostic and monitoring systems. As such, DanMedical is the leader in innovative telemedicine healthcare supporting systems, developed for the sole purpose of keeping people out of hospital unless they actually need to be there. The DanMedical vision is equal global healthcare provision for all. DanMedical has designed the 'DanMedical Analysis Systems (D-MAS)'. D-MAS has outstanding eHealth and telemedicine capabilities, with advanced features including integration with patient record system, local interpretation, encrypted email facility, real time connectivity anywhere in the world and video conference facilities. As such, D-MAS is a complete solution to the demanding needs of any healthcare system.

D-MAS virtually displays and electronically captures, interprets and communicates physiological screening results such as 12 lead ECG's, spirometry, lung function, blood pressure, pulse, and pulse oximetry, as well as imaging for dermatology, wound care and tissue viability, whilst linking to and from any on-line location in the world. This means that D-MAS is a new and unique class of physiological screening technology that delivers significant benefits in a wide range of therapy areas, patient settings and environments, which is particularly relevant to remote and rural communities. D-MAS is not limited to the areas described, other screening facilities can be dropped into D-MAS as required.

For more details visit www.danmedical.com

E-HEALTH AND TELEMEDICINE

E-HEALTH IS HAVING A HUGE IMPACT ON MODERN HEALTHCARE, WITH SCENARIOS THAT WERE INCONCEIVABLE JUST TEN YEARS AGO, NOW BECOMING A REALITY. PATIENTS IN REMOTE REGIONS OF THE WORLD CAN BE TREATED FROM A DISTANCE, EVEN BY A PHYSICIAN IN ANOTHER COUNTRY OR CONTINENT, THROUGH THE USE OF TELEHEALTH. HEALTH PROFESSIONALS CAN UPGRADE THEIR SKILLS THROUGH E-LEARNING WITHOUT NEEDING TO LEAVE THEIR DESKS AND NATIONAL NETWORKS OF ELECTRONIC HEALTH RECORDS CAN MAKE A PATIENT'S ENTIRE HISTORY AVAILABLE AT THE TOUCH OF A BUTTON.

34 35

The consumer healthcare market refers to all private financed products and services connected to health and wellbeing which are not insurance based. The buying initiative or decision for products and services comes directly from the consumer. The demand includes: prevention and treatment services of all kinds (e.g. dental services, beauty surgery, eye laser, implants, gene analysis), self-monitoring devices (e.g. blood pressure device, step counter, fitness devices), health-oriented travelling, OTC drugs (self-medication) and functional food.

These products are designed for the in-home treatment and prevention of medical conditions and ailments as well as the enhancement of overall health and well-being. Other areas include incontinence care, point of care diagnostics, non drug based alternatives, skin care, vision care including breathable contact lenses and smoking-cessation treatments.

The UK has a highly competitive healthcare market and some world leading products in this category.

ATTENDS HEALTHCARE GROUP are exclusively focused and dedicated to the design, production and distribution of disposable continence care products. Attends corporate headquarters is in Newcastle upon Tyne, England, with production centralised in Aneby, Sweden. Attends is represented in more than 20 countries in Europe, the Middle East and Australasia, via local subsidiary companies or distributor partners, with sales exceeding € 120 million.

Attends range of body worn disposable products caters for all types and degrees of incontinence, together with surface protection pads, fixation pants and skincare products. Significant factors in the continued progress and success of Attends Healthcare Group are a world class manufacturing facility, efficient customer service and logistical support, combined with intimate knowledge and understanding of their customer needs.

Attends India, is a new venture focused and committed to transforming the lives of carers and wearers by introducing products that offer exceptional skin dryness. Attends are passionate about maintaining skin integrity in frail and elderly incontinent clients. Attends believe that quality products, at the right price, with continued availability and ongoing clinical education and support, improve the lives and well being of their customers worldwide.

For more information visit www.attendshealthcare.com

MARSHALL CURTIS LIMITED, a manufacturer of the Aquamed MA range of waterless bathing systems with products like Bed Bath, Shampoo Cap etc., and organic sensitive skin care products, is based in Didcot, UK.

Stephen Ley, the Managing Director, is a pioneer in developing these products which are now sold in the UK, Europe and other countries worldwide. Their waterless bathing products help hospital patients have more hygienic bed baths, reducing nursing time and also reducing the spread of infection. These products are also ideal for elderly people, those confined to bed, and the disabled. Marshall Curtis has recently signed an exclusive distribution agreement with Cadential Technologies Pvt. Ltd. a Bangalore-based marketing and distribution company, for distribution of its products in India and the surrounding countries.

For more information please visit www.marshallcurtis.com and www.cadential.in

CONSUMER HEALTHCARE

36 37

CLINOVA is a pharmaceutical company focused on developing, manufacturing and marketing a broad range of pharmaceutical products and diagnostic devices. Clinova has its global headquarters in Southampton, UK. Clinova has developed Covaflu FFP3 disposable face masks to prevent harmful particles from entering the lungs by providing FFP3 particle filtration. Covaflu protects healthy individuals, by preventing person to person airborne contamination and filters out approximately 99% of droplets, which are 0.3 microns in size and over.

Clinova has also developed Quash, a natural alcohol and chemical free hand sanitizer. Quash is a patented formulation of 100% natural ingredients that has been proven in independent laboratory tests to kill 99.9% of common bacteria, viruses and fungi that can cause illness. The product also encapsulates vitamins and minerals to help moisturise and nourish the skin.

In December 2009, Clinova launched Bacticure cream for the treatment of topical bacterial infections. Bacticure's ingredients are 100% natural (plant based) and Bacticure does not contain any alcohol. The product has a potent, broad spectrum antimicrobial activity as well as significant antifungal activity.

Clinova is developing a revolutionary insect repellent patch to help prevent mosquito bites. Clinova has proven the effectiveness of the anti-mosquito patch for apparel treatment in laboratory tests with yellow fever mosquitoes. Clinova is currently completing phase 3 studies of Clin3004 and expects the candidate to progress to launch in April, 2010.

Clinova has a number of other products in clinical development.

For information please visit www.clinova.co.uk

38 39

The respiratory anaesthetics sector comprises anaesthesia machines, ventilators, and patient monitoring devices. Most of the innovations have originated from collaborations between anaesthetists, companies and universities. Apart from the development of cutting-edge medical devices, the key to success in this sector is the ability to offer strong after-sales service and support.

The University of Oxford is undertaking research of direct relevance to respiratory anaesthetics including the development of new apparatus to measure lung function using forced inspired oxygen gas, controlled by a laptop computer, making it suitable for use at the beside or on anaesthetised patients in operating theaters.

Scientists at the University are also investigating the development of a membrane covered multimicroelectrode array sensor, to measure the concentration of oxygen and carbon dioxide in gas mixtures. Simple changes to the membrane mixture will also allow the measurement of the concentration of inhalational anaesthetic agents, in gas delivered to patients.

Although the market is dominated by multinationals, the UK has a large number of smaller companies and divisions of larger companies occupying niche positions.

SMITHS MEDICAL INTERNATIONAL, based out of Ashford, Kent, UK, is a leading global manufacturer and supplier of medical devices and equipment for use in Intensive Care, Anaesthesiology, Cardiology, Emergency, IVF, homecare and Veterinary environment. It occupies a large part of the Smiths Group plc which is a FTSE 100 company.

From intuitive I.V. access systems and innovative infusion pump technology, to patient monitoring and diagnostic devices, Smiths Medical's advanced technologies have set the standard for reliable, high quality therapy solutions.

The company has global sales of over £815million (2009) with strong operating margins and its businesses operate virtually in most countries across the globe. Its key focus is in three main segments namely, Vital Care, Medication Delivery and Safety.

Smiths Medical has direct presence through its fully owned affiliates in 20 countries, and in other countries, its products are sold through a 300 strong distributor network. Working closely with their exclusive distributor, M/s. Hansraj Nayyar Medical, Smiths Medical has been doing business in India for over two decades.

As part of their expansion plans in India, they have appointed Medion Healthcare Pvt. Ltd., Mumbai, as the exclusive distributors for the infusion range of products, which include Syringe and Volumetric Pumps. They have appointed Meditek Systems, New Delhi, as the exclusive distributor in India for their Medex Interventional Cardiology range of products. Their key customers include Apollo Hospitals, Fortis Group of Hospitals, Narayana Hrudayalaya, Columbia Asia Hospitals, Bombay Hospital, Tata Memorial Cancer Hospital and Research Centre, AIIMS, PGIMER, SGPGI and Defence Hospitals.

Smiths Medical's market-leading portfolio of products is guided by the 11 reliable brands that clinicians have known and trusted for many years. They remain committed to helping clinicians care for their patients by providing high-quality, cost-effective products they can depend on to deliver medication, provide vital care, and keep people safe.

For more information visit www.smiths-medical.com

RESPIRATORY ANAESTHETICS IMPORTANT INNOVATIONS ARE TAKING PLACE IN ANAESTHETIC AND RESPIRATORY PRODUCTS

Picture courtesy Smiths Medical

40 41

The UK is the world leader in healthcare education and training, being home to 29 medical schools, including many deemed to be world class, and 19 Royal Colleges. It is home to 4 of the world's top 20 universities, with the Universities of Cambridge and Oxford being ranked second and third respective, followed by Imperial College of London and the London School of Economics.

The cutting-edge research being undertaken by the UK's universities attracts industry, with life science clusters around Cambridge, Oxford, London, Nottingham and Liverpool as well as in Scotland.

Alongside the 20 universities providing medical education, there are 108 higher education institutions providing undergraduate courses in nursing and applied health professions and each year 170 UK universities/ higher education institutes produce approximately 300,000 graduates, and almost 100,000 post graduates at a Masters level, and 15,000 at a doctorate level.

The UK medical training education and training industry has a long history of excellence in training overseas doctors and healthcare professionals. Leaders in medicine throughout the world have received medical education in the UK. Its hospitals and other clinical settings have set best in class standards for developing a high-performing and innovative workforce. They have focused on building and spreading skills and proven innovations across various aspects of healthcare areas, ranging from prevention of ill health, acute care and chronic conditions, cancer

and cardiovascular services, diabetes, mental heath services, stroke care and infectious diseases.

With growing needs for trained medical professionals and administrators globally, the UK is ideally poised to offer its services in the medical training and training sector. The UK has some of the world's most advanced Hospitals, Universities and Colleges that offer all an inclusive range of training and education specialisation.

King's College London School of Medicine is one of the country's largest and oldest medical schools. The School's internationally leading research programmes include two MRC Centres in asthma and transplantation. The School also delivers both undergraduate and graduate education programmes.

The Medical Sciences Division at Oxford University is an internationally recognized centre of excellence for biomedical and clinical research and teaching, and the largest academic division in the University of Oxford. World-leading programmes, housed in state-of-the-art facilities, cover the full range of scientific endeavour from the molecule to the population.

The School of Clinical Medicine at the University of Cambridge offers students a first class scientific approach to medicine combined with learning and teaching programmes that emphasise the development of excellence in the clinical, communication, attitudinal and practical skills required for good medical practice.

MEDICAL EDUCATION AND TRAININGTHE TRAINING GATEWAY is a free service which helps UK and international public and private sector organisations address their skills needs by providing a single point of contact through which to source corporate, vocational and executive training and educational partnerships from UK universities and colleges.

Allowing easy and direct access to over 2300 named coordinators in every UK university and around 60 colleges, the Training Gateway provides the most comprehensive access to university level corporate, vocational and specialist training in the UK including medical and health related expertise and training.

As well as providing access to training courses, The Training Gateway helps businesses identify universities that can accredit their own in house training programmes, develop bespoke packages for medical professionals and health care managers, as well as online or work-based learning programmes.

The Training Gateway also works with overseas educational institutions who wish to partner with UK universities and colleges for UK recognition, joint degrees, Foundation degrees, professional training for staff in universities or colleges or other types of educational partnerships, including the development of joint programmes.

For more details visit www.thetraininggateway.com

42 43

THE UNIVERSITY OF YORK, DEPARTMENT OF HEALTH SCIENCES, has an international reputation for combining world-class research with high quality teaching and learning to make a positive impact in healthcare. Located in York, famous for its exquisite architecture, vibrant café- culture and iconic York Minster, the Department of Health Sciences train over 9,000 health professionals in Health and Social Care, from Diploma level to Masters Level. Their health services research, including nursing and midwifery, are recognised internationally, in terms of its originality, significance and rigour, with 35% recognised as world-leading.

York offers a broad range of educational programmes in the health and healthcare sector, at both undergraduate and postgraduate levels. Students benefit from studying in an environment where findings from a world class health research programme are rapidly integrated into their education and research courses, delivered by innovative, forward-thinking academics who are international leaders in their field. Successful completion of either diploma or degree courses leads to professional registration as a nurse in one of four specialist areas (branches) – Adult, Child, Learning Disability or Mental Health nursing. The department also develops midwives who are able to act as autonomous practitioners for women accessing maternity care.

Their Graduate School provides an exciting postgraduate learning environment with a flexible programme of modules and study pathways that are relevant to the needs of health professionals, managers and those seeking a career in health services research, nationally and internationally. They offer a range of full-time and part-time Masters' programmes, and a MPhil/PhD Programme in Health Sciences. It is possible to take modules independently of a full programme. Continuous professional development programmes for practitioners, managers and researchers in the health and social care sector are designed to equip professionals and managers with knowledge through evidence based practice in order to meet patients' and clients' needs.

For more details visit www.york.ac.uk/healthsciences

MIDDLESEX UNIVERSITY along with its collaborative partner RILA has developed several Postgraduate courses for training doctors in specialities such as Cardiology, Diabetes, Musculoskeletal Medicine, etc.

These Postgraduate courses have accreditation from both Middlesex University and the Royal College of General Practitioners and are widely adopted by the National Health Service (NHS) organisations in the UK, e.g. hospitals, community health organisations, primary health care etc., as training programs for their professional clinical staff. Doctors can gain higher qualifications, promotions and enhanced quality of care.

Middlesex University and Rila have had a number of Indian doctors train successfully within the UK, but a far greater number would be prepared to follow the Postgraduate medical courses if available in India. As a consequence, the University and Rila launched their Postgraduate Diploma in Cardiology in India in 2007 and this has proved extremely popular. This is a UK based qualification but taught, delivered and examined in India with the assistance of accredited Indian healthcare organisations.

Chronic diseases including diabetes have become major public health issues and need to be addressed to contain what is near epidemic in UK and India. Education for doctors is fundamental to combat this scourge in particular in diabetes and cardiology. University of Middlesex and Rila are keen to meet Indian healthcare professionals and doctors to develop similar postgraduate programmes in particular in diabetes and cardiology.

For more details visit www.apwsi.co.uk

44 45

BMJ GROUP is a world leading provider of trusted medical information and services and is committed to supporting the highest standards of practice in healthcare through their range of product offerings including :

�World leading medical journals, both general and specialty

�Specialty journals include Gut, Heart, Journal of Neurology, Neurosurgery and Psychiatry plus Acupuncture in Medicine which is amongst the newest additions

�Evidence based medicine – tools and services �Best Practice, the new point of care tool is

designed to fit information around the real, diverse and evolving medical information needs of clinicians

�Learning and CPD resources

BMJ Learning is the leading online provider of continuing professional development and postgraduate training for doctors and other healthcare professionals.

These offerings combine to provide the medical community with a comprehensive information support system aimed at improving standards while also inspiring innovative thinking and new ideas. BMJ is committed to promoting the use of medical evidence so that professionals as well as patients can make better healthcare decisions.

They are available in India, and their list of customers across South Asia include : National Medical Library-New Delhi, Govt & Private Medical Colleges & Universities across the country, Hinduja Hospital - Mumbai, Max Hospital- New Delhi, Aga Khan University & Hospital-Karachi, Eli Lilly, Schering Plough, Pfizer, Piramal Healthcare, etc.

For more details visit www.bmjgroup.com

THE UNIVERSITY OF CENTRAL LANCASHIRE (UCLan) is now one of the largest Universities in the UK with a community of more than 35,000 students, 500 undergraduate courses and 180 postgraduate courses. UCLan was only created in 1992 but its roots go back to 1828 and the founding of the Institution for the Diffusion of Knowledge. From this small acorn, UCLan has propelled itself into becoming a major player, both at home and across the world.

UCLan recently invested £60 million on new campus developments – including the £15.3 million 'media factory' to aid work in art, design and performing arts, a £5.5 million School of Dentistry (the first to be opened in the UK for 100 years) and the first School of Pharmacy and Pharmaceutical Sciences in Lancashire. A new £12.5 million facility for the University's renowned Forensic Science courses has also been unveiled, which will house a range of science-focused students.

The Faculty of Science and Technology offers a wide-ranging portfolio of courses including Forensic Science, Chemistry, Archaeology, Pharmacy, Biomedical Science, Physiology and Pharmacology, Psychology, and Exercise Science. UCLan has close relationships with many overseas institutions such as the Padmashree Dr. D. Y. Patil University in Mumbai, where students study for 2 years in India before finishing their BSc (Hons) in Biomedical Science at UCLan. One-year taught Masters courses are available, in subjects such as Cancer Biology and Therapy, Pharmacy, Biomedical Sciences, Forensic Anthropology,

Document Analysis, and DNA Profiling. Research MSc, MPhil, MD and PhD degrees are also available. In addition, UCLan is currently developing a postgraduate research institute in Mumbai, India, in collaboration with an Indian partner leading to either MSc, MPhil. MD or PhD by research. This will enable prospective students to pursue studies for a higher research degree in India.

UCLan has been ranked as the UK's top modern university and top overall in the North West by the Times Higher Education (THE) Student Experience Survey 2009/10 and was awarded their top prize for 'outstanding support for overseas students.'

For further information, please email cenquiries@uclan.ac.uk. For biomedicine and forensic science postgraduate courses contact either Professor Jaipaul Singh (jsingh3@uclan.ac.uk) or Professor Robert W. Lea (rwlea@uclan.ac.uk).

46 47

Any collaboration between public bodies, such as local authorities or central government, and private companies, tends to be referred to a public-private partnership (PPP). The UK Government has used PPP to expand and secure improvements in public health services. The efficiency of private sector companies is combined with health excellence of public sector providers, to run health services in line with agreed performance indicators for set periods of time. In trying to bring the public and private sector together, management skills and financial acumen of the business community help to deliver value for money.

The United Kingdom has developed considerable expertise in the use of Public Private Partnerships (PPPs) in the health sector with over 280 schemes worth some £13.6 billion, making it the largest health PPP programme in the world. Such projects have ranged from the provision of clean, modern, purpose-built premises for general practitioners through to complex tertiary hospitals such as the 1,248 bed Barts and London Royal Hospital which is a centre of cancer and cardiac excellence and the largest PPP hospital project of its kind in the world.

On the public sector side, organisations like Partnerships UK (PUK) and the Department of Health Private Finance Unit, have been heavily involved in helping the UK Government deliver its wide range of PPP health schemes. The UK public sector has developed a wealth of best practice in PPP project preparation, contract development, value for money assessment and contract management.

On the back of this programme, the UK private sector has also developed extensive financial, legal, technical, project management, construction and facilities management expertise to support both the public sector procuring authorities and the private sector bidders as well as to finance, construct, maintain and operate these facilities.

PUBLIC PRIVATE PARTNERSHIPS (PPP)EVERSHEDS PPP work is led by their project and infrastructure finance group. Worldwide, this group comprises over 150 specialist projects lawyers and 30 partners. About a third of this resource is based in the UK.

Eversheds' infrastructure work has been one of the key platforms for the growth of the firm. They are now one of the largest law firms in the world, with about 400 partners, 4,000 people and 40 offices in 25 countries. Through this network, they are well placed to support their clients across the world, and have been particularly active in Europe, India, the Middle East, Latin America, Africa and China.

Their project and infrastructure finance group specialises in PPP projects both in the UK and in international jurisdictions. Within the UK PPP market alone, they have advised on 250 of the 800 closed projects. Many of these have been in the healthcare sector.

The PPP market in the UK is well developed. Many other countries with PPP programmes look to the UK model as an established starting point for their own schemes. Eversheds have successfully worked in a number of jurisdictions, including India, to help share the lessons learnt from the UK PPP programme.

A key example of this is their advice to a contractor who is part of the preferred bidder consortium on the NSK Karolinska health care project, one of the largest hospital projects in Europe and Sweden's first PPP.

Eversheds also regularly advise on the legal issues relating to medical equipment and technology use, both within PPP facilities and in stand alone arrangements. For example, they have advised the London Clinic on purchase and maintenance contracts with suppliers of radiotherapy equipment.

For more details visit www.eversheds.com

48 49

The UK has some of the most renowned architects in the world, but it is not widely known that many of the UK's architects have been closely involved in the design and development of healthcare facilities for the 21st century. Multi-billion pound NHS building programs plus heavy investment from the private sector have catalyzed some ground breaking developments.

Modern healthcare facilities need better functionality to improve hospital efficiency, reduce energy costs and improve hygiene. Scientific analysis of patient processes and flows through buildings, can dramatically improve how healthcare is delivered to patients. With expensive real estate and limited building budgets, architects need to realise maximum value from the land space available. UK firms have produced award winning designs for facilities ranging from small city centre units to large scale centres for growing towns.

Energy costs are a major budgetary factor and smart design of lighting, heating, ventilation, and waste systems can deliver major savings. UK architects have developed cutting edge solutions to improving performance in these areas. Hygiene remains the most important factor when considering how to handle patients with different infectious conditions. Good design of facilities and materials used within facilities, can help prevent the spread of germs, and reduce cleaning and maintenance costs.

DESIGN AND BUILDING OF HEALTHCARE FACILITIESRecognising the need for a wide range of consultancy and design services to assist and support healthcare clients in India, Technopak and DEVEREUX ARCHITECTS have formed a strategic alliance. This combines Technopak's leading edge consultancy services in the healthcare domain with Devereux Architects' extensive international healthcare design experience and expertise. Devereux Architects are one of the UK's leading healthcare architects who have experience in Europe, the Middle East, and the Caribbean. The practice's experience covers projects for government health services, such as the UK National Health Service (NHS) and for independent health providers. This experience also covers all types of healthcare facility including acute and tertiary/specialist hospitals; community hospitals/local care centres providing intermediate care; primary care centres and polyclinics; treatment centres; mental health facilities and nursing and care homes.

Technopak are one of India's leading management consulting firms, engaged in building and enhancing business capabilities for leading Indian and international companies across diverse sectors, by offering end-to-end services that are unique due to their rich experience, strong industry relationships and a global spread.The healthcare practice is uniquely positioned to advise clients based on its sectoral expertise in design, insight into healthcare operations in India and its “concept to commissioning” capabilities. The practice's experience ranges from Medical Planning for Specialty Hospitals to Feasibility

Assessment, Conceptualization, Strategy and Business Planning for large infrastructural projects, such as an 8000 bed Healthcare City Development. The practice has also undertaken a wide variety of due diligence assignments involving business, operational and infrastructural assessment of existing hospitals with respect to operational processes and protocols, facility planning, medical regulatory compliance and accreditation readiness as per National Accreditation Board of Hospital (NABH) norms. Technopak and Devereux Architects together bring to their clients design leadership, vast healthcare design experience and global standards, with well established local presence and a deep understanding of and insight into local operations.

Technopak & Devereux Architects can offer healthcare clients the following services; Market Analysis, Assessment of Needs/Health Planning, Capacity Planning, Business Case Preparation, Assessment of Geographic Locations, Site Finding and Site Assessments, Brief Preparation, Masterplanning, Development Strategies, Architectural Design Services, Medical Planning, Procurement Advice, Project Management, Project Delivery and Commissioning and Equipment Planning.

For more details visit www.devereuxarchitects.com

50 51

MJ MEDICAL is a leading international healthcare consultancy specialising in hospital and clinical equipment planning, design and procurement management. Their portfolio of consultancy services spans the continuum of the hospital planning, design and management process, from project inception to completion.

MJ Medical's key services include health and equipment planning, project research and feasibility studies, medical architecture advice for hospital and clinical facilities, medical equipment scheduling, specifications, tender bid analysis, procurement management including testing and commissioning, and management of installations.

Established in 1987, MJ Medical employs over 30 technical and commercial staff, and works with companies and industry stakeholders in every region of the world. The experience and expertise MJ Medical draws upon equips them to offer a refined and confident approach in dealing with the challenges diverse healthcare facilities present. As a result, MJ Medical have been highly successful in securing new and repeat commissions in the healthcare sector and their clients include Ministries of Heath, local and international Governments and organisations, Public Private Partnerships, NHS Trusts, and voluntary sector organisations.

The company has played a key part in landmark healthcare facilities and the health and equipment planning design of new and innovative structures. MJ Medical's leadership in the sector is reflected in its global collaboration with leading industry

bodies such as the World Health Organization, the Department of Health, and the Association of British Healthcare Industries, and specialises in delivering ambitious and innovative healthcare projects that deliver to both clients and the communities who use them every day.

MJ Medical are now looking to expand their full range of services into the Indian market and are seeking to develop relationships with agents, contractors and healthcare providers undertaking healthcare projects in the country.

For further information please visit: www.mjmedical.com

AUSTIN-SMITH:LORD have over 20 years experience within the healthcare sector ranging from acute care and diagnostic facilities to local care provision health centres. Designing healthcare buildings should be considered as a privilege for any architect, and at Austin-Smith:Lord, they approach the design of the buildings as they would other significant public commissions, from a process which starts with understanding the individual users; patients, staff and visitors. It is well established that good design can directly contribute to the users' well being and patient recovery, and by designing welcoming and accessible buildings where people can easily orientate themselves, they aim to provide first class buildings which facilitate effective treatment and recovery. Maximising daylight and natural ventilation throughout and designing patient areas to be as non-institutional as possible, through careful selection of colour, materials lighting to create a non-threatening environment, are essential considerations in their approach.

Austin-Smith:Lord are one of the top 10 architectural practices in the UK and cover many diverse sectors including, education, culture, residential, industrial, urban design, master-planning and landscape. Their experience in healthcare is largely in primary care and specialist diagnostics, covering both private and public sectors, and they have recently expanded internationally with an extremely significant cultural project in Abu Dhabi.

For further information please visit www.austinsmithlord.com

52 53

Arup has been involved in Public-Private Partnership healthcare projects around the world in the different roles associated with this procurement approach from front end financial and technical advisor to their healthcare clients, to the role of technical advisor and also the traditional role of contractor's designer.

The following highlights some key aspects related to their services : research related to infection control within acute facilities, development of low cost community facilities for the developing nations through the WHO, delivery of indigenous capital works healthcare programmes in Australia, life cycle costing studies associated with healthcare facilities, workforce development through a Clinical Leaders Network in the UK, logistics master planning of site and within the facility improving utilization, and the use of natural ventilation in the design of hospitals and clinics.

For more details visit www.arup.com

ARUP is a global firm of designers, engineers, planners and business consultants providing a diverse range of professional services to clients around the world, and has been in existence for over 60 years. They have over 9,000 staff working in more than 90 offices in 37 countries.

Arup has been working in India for more than 40 years on a wide range of building, infrastructure and consulting projects and is able to draw on the full range of Arup services and expertise from around the world. A key project was the completion of the design of the Rajiv Gandhi International Airport, Hyderabad. Arup Engineering Design and Consulting Services India Private Limited is a wholly owned subsidiary of the Arup Group, with an office located in Bandra Kurla Complex, Mumbai, since January 2008.

Healthcare is one of Arup's key global business sectors, where they have completed more than 3,000 projects worldwide, from the complete engineering design of major hospital facilities through to the project management of other organizations, to the provision of facilities management resources where maintenance management is required.

54 55

Experience gained from developing one of the world’s leading healthcare industries has made the UK a natural home for consultancy practices. There are now over 500 of them, ranging from sole practitioners to multinational firms. These companies offer advice on all aspects of health service organisation, hospital and primary care management and training and development.

British consultants have been sharing their expertise in areas such as:

�managing support services or government hospitals in Malaysia and Saudi Arabia

�advising on the reform of national health insurance arrangements in Slovenia and primary healthcare management in Russia, and

�supplying surgical training in Germany and Australia

Consultancy services have included support in organisational management and development, national healthcare financing systems, or financial management of primary and secondary care providers. There has also been growth in demand for human resources development based on UK standards, which have enriched the capabilities of overseas healthcare providers. Examples of development areas include manpower planning, recruitment services, and education and training. In the area of service delivery the UK also excels. It provides overseas support in the development of healthcare facility strategies, setting up financing arrangements such as public finance partnership solutions, and also project-manages the construction of facilities.

CONSULTANCYTHE UK HAS DEVELOPED A HIGH LEVEL OF EXPERTISE IN NON-CLINICAL CONSULTANCY WHICH IT SHARES WITH THE REST OF THE WORLD

PEOPLE IN HEALTH (PIH) is part of the Abermed Group which is a subsidiary of International SOS. PiH is an international healthcare consultancy, providing skilled expertise in all sectors and all disciplines of health. PiH is increasingly focused on working with national and international organizations to help improve health care services in emerging markets. People in Health is committed to utilizing its unique knowledge-base to support the improvement of health for all. People in Health provides strategic healthcare consultancy to Governments and Governmental agencies; to NGO’s and Charities; to all types of Health Deliverers; to private sector industries such as pharmaceuticals, biotechnology, medical devices/diagnostics, and consumer health. People in Health provides commercial, operational, scientific and HR consultancy services and specialist support services in Human Capital, including the provision of interim managers and scientists and retained executive search. The consultancy is directed by a small core team in London, Aberdeen and Paris. This group can draw on the services of hundreds of independent healthcare consultants throughout Europe and elsewhere. These consultants are highly experienced in all disciplines and specialisations, and in all sectors, of health delivery and the health industry. These consultants only become a cost factor when operating on projects for the consultancy and this enables People in Health to offer very professional and specialist advice at very competitive fees.

People in Health has the experience and track record of working successfully with Indian health industry companies on a variety of issues. PiH has access to the knowledge and skills to deliver flexible solutions to resolve health care industry challenges in an affordable and bespoke manner, and they are keen to expand their range of services in to the Indian market.

For more details visit www.peopleinhealth.com

56 57

HIGHFIELD BUSINESS CONSULTANTS LTD. (HBC) was established in 2000 to work with international organisations looking for opportunities to enter or expand their business in the UK healthcare market. Since then HBC has worked with numerous organisations from major multinational companies to start ups across the healthcare service provision, medical device and diagnostic sectors.

Sue is also a Non-Executive Director at Weston Area Health Trust, a NHS acute hospital and a member of the UKTI Healthcare Advisory Board and India Strategy Group.

For more details contact Sue Jamison at sue.jamison@hbc-uk.com

SUE JAMISON is a Healthcare Consultant with experience of working for UK and internationally leading healthcare and life science companies. Sue has a track record of initiating and implementing strategic development, and exploiting profitable business opportunities between commercial organisations and their target healthcare market. Working with both the private and public healthcare sector, Sue is able to offer a practical and flexible approach to best meet the client’s needs for all aspects of strategic planning, business development, identification of partner and acquisition targets and market entry management. Sue's experience includes various positions over a period of 10 years with Baxter Healthcare and as International Sales and Marketing Director for Smiths Medical. Sue then joined Gyrus, a UK based start-up healthcare company, as their Sales and Marketing Director. Gyrus was subsequently listed on the London Stock Exchange.

58 59

Computer technology is central to many of the healthcare industry's developments, making IT a major growth area in the sector. IT can be applied to all aspects of patient care and assessment. The development of software applications is also one of the most rapidly developing sectors. It comprises over 120 companies which have identified openings in clinical laboratory systems, healthcare administration, patient records and clinical procedures. Hardware products are also currently being developed for use in clinical applications. The largest IT project in the UK healthcare sector to date is the 'National Programme for IT' (NPfIT), which is being delivered by the new Department of Health agency 'NHS Connecting for Health' to improve patient care and services in the NHS. Over the next ten years the NPfIT will connect over 30,000 GPs in England to almost 300 hospitals, and give patients access to their personal health and care information, transforming the way the NHS works.

BT is the developer of a secure managed network for the NHS called NHSnet. Users can share information, access information from other NHSnet users and exchange emails through the system. Research in Motion® (RIM), whose BlackBerry® devices are being used to help the transplant team access the latest information about patients on waiting lists at Addenbrooke's Hospital, Cambridge, and thus simplify the process of making complex decisions about patient care.

HEALTHCARE INFORMATION TECHNOLOGYHEALTHCARE INFORMATION TECHNOLOGY IS A MAJOR GROWTH AREA

One key strand of NPfIT is telemedicine, which will allow the re-engineering of service delivery and give the public fast and convenient access to information, advice and care via telephone and online services. NPfIT is also implementing electronic prescription services and booking of appointments. Multinationals as well as domestic UK IT suppliers have already been awarded NpfIT contracts. Companies awarded business include:Accenture, BT, Cable & Wireless, Atos Origin, CSC and Fujitsu Alliance, iSOFT, Oracle, Sun Microsystems, and IDX.

60 61

TOUMAZ TECHNOLOGY LTD. now a wholly owned subsidiary of Toumaz Holdings, was founded to exploit developments in ultra-low power silicon chip technology at Imperial College London. The company's proprietary Advanced Mixed Signal - AMx™ - technology resulted from development of ultra low power techniques in signal processing and wireless systems leading to chips consuming up to 100 times less power than other state-of-the art devices.

Today, Toumaz is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions. Toumaz's ultra low-power smart sensor interface and transceiver platform – Sensium™ – enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx) ™ technology, Sensium provides the enabling technology to connect patients and mobile individual to healthcare providers – simply, affordably and unobtrusively.

SAVIENCE LTD. is a UK-based software development company specializing in cost-effective, automatic reception systems for the healthcare sector.

Savience has developed highly successful patient check-in systems for hospitals, clinics, GP surgeries and dental practices. Its easy-to-use patient check-in touch screens and reception management software tools enable resource savings and create an improved patient experience by eliminating queues and bottlenecks.Savience technology is becoming increasingly popular and is currently used in more than 800 doctors' surgeries, dental practices and hospitals.Savience takes the time to understand the specific challenges faced by organisations with high volume patient check-in requirements. Its solutions address key issues such as data confidentiality, robust systems, compatibility and usability. Savience works closely with the National Health Service (NHS) in the UK and won the 2009 Bioscience Award for the best NHS collaboration.

The Savience Assure suite of products provides robust and proven solutions for high volume hospital departments and healthcare clinics keen to enhance efficiency and improve patients' experience.

Savience Clarity – a fully integrated solution. This suite of hospital products delivers streamlined support from the minute a patient arrives, right through to appointment attendance.Savience Pathfinder – instant route planning for patients. The modern way to guide patients through large or complex buildings and ensure they arrive for every appointment punctually.Savience Survey – touch screen questionnaires and screening surveys, collates patient feedback and personal information without the administrative overheads. Interactive screens make it easy for the patient. Electronic data capture and storage makes it easy on staff.

Savience is a vibrant, independent company with a head office in Towcester, UK.

For more details visit www.savience.com

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

Toumaz is currently completing its end-to-end platform for wireless monitoring which will be made available under licence to healthcare providers globally.

For more information, visit www.toumaz.com

62 63